This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. For each condition under consideration, a vote was taken to determine if the Board would make a recommendation to the IDPH Director to approve the condition for addition to the list of qualifying conditions.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Work with remaining conditional license-holders to transition to fully operational dispensaries serving both medical patients and adult use customers. Find detailed information about this topic here.)
The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Eight-one percent of subjects reported “at least moderate improvement in their condition … without experiencing serious adverse events.”
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Adverse events were mostly mild and resolved spontaneously.
The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.
NORML has previously written on the data showing a multi-directional association between cannabis and psychiatric illnesses, and we have cautioned that those predisposed to psychosis or other disorders may be at higher risk for adverse events. But it is not evidence that marijuana in any way causes the condition.
1 When we invited Cannigma readers to try Slumber’s Deep Zzzs gummies for sleep, we were particularly interested in digging into the data on sleep quality – not just total sleep time. 2 While the data collection effort did not include a control group, the prime findings were found to be statistically significant.
His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior.
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.
RYAH is pleased to contribute RYAH’s IoT devices and data platform and work with Medicann toward perfecting prescribing practices and dosing regimens,” said Gregory Wagner , CEO of RYAH Group, Inc. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle.
Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.
It is also crucial so that the correct data is collected in order to inform further research and clinical trials that are necessary for cannabis medicines to reach the UK National Health Service. Nurses are an integral part of any healthcare team, as they are tireless advocates for their patients and have unmatched organizational skills.
Medical Marijuana use has shown potential benefits in managing symptoms and improving the quality of life for individuals with various health conditions. This is the reason every Medical Marijuana state lists HIV/AIDS as one of their qualifying medical conditions.
According to the American Psychiatric Association , PTSD is a “psychiatric disorder that may occur in people who have experienced or witnessed a traumatic event such as natural disaster, as a serious accident, a terrorist act, war/combat or rape or who have been threatened with death, sexual violence or serious injury”.
This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. Training will be provided within the research program for licensed practitioners to assess the safety of psychedelic medicines and to classify and report positive and adverse events.
The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. “Our billion by 2027.
But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications. Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g.,
Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.
Our evidence-based scientific approach has enabled us to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. Forward-looking statements. Some statements in this release may contain forward-looking information.
High Tide gains access to Daily High Club’s over 15,000 subscription box members who are ideal customers for High Tide to potentially launch cannabis subscription boxes in the event of U.S. 1 As of June 21st, 2021, based on analytics data provided by Alexa Internet, Inc. Traffic data provided by Google Analytics.
CBD continues to flourish in the markets despite lack of federal regulations, and we’ve identified some significant events that indicate there’s no sign it’s stopping. Manufacturers are responsible for certifying records, including all product data, which includes, for example, information on formulation, labeling, and DEA Schedule.
“This impressive group represents well-known leaders in the psychedelic and addiction fields and will help usher in a greater understanding of the science and data behind what we expect to be the most effective treatments for many mental health conditions ever available.”.
1 All sales figured sourced from BDSA Sales Data and the Company’s internal calculations. 2 All sales figures sourced from the May 2021 BDSA Sales Data. This press release includes market and industry data that has been obtained from third party sources, including industry publications.
You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry. The Realm of Caring.
SOL Global’ s largest core holdings have achieved liquidity events and produced positive returns on investment. The Company believes this non-IFRS measure does not only provide management with comparable financial data for internal financial analysis but also provides meaningful supplemental information to investors. at May 31, 2020.
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.
The Company disclaims any obligation to update developments of these risk factors or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments. federal securities laws that are subject to risks and uncertainties.
The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has over $19 billion of assets under management and 95 ETFs listed on major Canadian stock exchanges.
Depression is a complex condition. The death of a loved one, losing a job, family crises, and a host of other potential events can all lead to the development of symptoms of depression. Ultimately, depression is a multifaceted condition that affects everyone who experiences it differently. Can Cannabis Treat Depression?
The interactions of the endocannabinoid system with the autonomic nervous system seem to be the driving force behind the reported cardiovascular adverse events [from cannabis],” wrote a group of researchers who recently reviewed years of cannabis studies 1. Cardiac-related mortality data from the U.S. increase among women 11.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. Accessed July 25, 2021.
We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We
Active research includes applications of machine learning and data mining as a member of the University of Alberta computational psychiatry group. These statements relate to future events or future performance. Cautionary Note on Forward-Looking Information. This news release contains forward?looking looking statements and forward?looking
“Each of the six locations has been issued a conditional RSA and work will begin immediately upon closing the Transactions to convert the stores to the Value Buds banner, and to obtain approval to open from the AGCO, just in time to take full advantage of the anticipated summer demand.” million in cash and $1.1
Based on government agency data, when viewed collectively, Ionic Brands manufacturing partners’ amount to the fifth-largest wholesale operator in Washington by revenue for the period of 2020. Actual results could be affected by subsequent events or determinations. Chairman & Chief Executive Officer. 1.253.248.7927.
CannaTech Tel Aviv 2019 was an absolute sensation, and we are already looking to Cape Town for our next big event. This revolutionary storage device maintains optimal conditions for cannabis freshness and potency, and makes monitoring, tracking, dispensing, and procuring medical cannabis accessible to everyday patients.
(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Safety and Tolerability (S&T) was assessed by asking participants to record Adverse Events (AEs).
A third item states that, “The Department shall authorize a dispensing organization that has been unable to find a suitable location within the BLS Region in which it was awarded a license to transfer its Conditional Adult Use Dispensing Organization License to another BLS Region specified by the Department.” “BLS
In addition to three social equity adult use cannabis dispensaries that opened in 2022, 189 other conditional licensees are in the process of receiving full dispensary license from IDFPR. Our data from 2022 shows that we are well on our way towards making that idea a reality,” said Governor JB Pritzker.
CannMed: For what conditions do you think CBG has the most promise? It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research. Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin.
The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. However, unlike a conventional new generic drug, cannabis use is not restricted to a single or limited set of conditions.
This partnership marks Mary AG’s first application of farm-level technology, taking its knowledge in automated systems and applying that expertise to a holistic, controlled growing condition that incorporates automated plant health assessment. About Mary Agrotechnologies Inc. CSE: MARY). Mary Agrotechnologies Inc.
Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain. Always consult a physician before making any decision on the treatment of a medical condition.
The study authors arrived at this estimate based on a series of user-response surveys, with the notation that “given the substantial non-response [to the survey questions] these data are subject to response bias.”. Acknowledging the limited scope of data, few mechanisms of cardiovascular risk have emerge. a heart attack).
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content